On the basis of differentiated clinical and laboratory parameters (renal function tests, coagulation tests, ADAMTS13 levels, PLASMIC score, and detected complement abnormalities), COVID-19-associated aHUS is somewhat more common in the literature published to date. This evidence concerns the gene ADAMTS13 and COVID-19.